In diagnosis, molecular diagnostics brought transformative changes leading to insight in research and treatment of many diseases.
Molecular diagnostics detect and measure the presence of genetic material or proteins associated with a specific health condition or disease, helping to uncover the underlying mechanisms of disease and enabling clinicians to tailor care at an individual level.
Molecular diagnostics is laboratory tests used to identify a disease, or the predisposition to a disease, by analyzing DNA- (deoxyribonucleic acid) or RNA (ribonucleic acid) or their proteins, in humans or, in the case of infections, in microbes. It includes all tests and methods to identify a disease and understand the predisposition for a disease analyzing DNA or RNA of an organism.
With the help of molecular diagnostic,the understanding of diseases is now possible at much earlier stage, which is not possible using traditional methods and it also facilitates understanding of gene pattern and detecting of cell behavior.
The market value for molecular diagnostics is expected to reach 19,683 Million in 2026. North America accounts for the highest market share followed by Europe and Asia-Pacific. In 2017, North America holds the market value of USD 3730 Million.
The market is driven by increasing number of incidence and prevalence of diseases like cancer, infectious disease, respiratory disorders, hematology disorders etc. Research and development of techniques in molecular diagnostics also influences the market.
Molecular diagnostics tests are applied in the area of infectious disease like human immunodeficiency virus(HIV), influenza virus detection etc., oncological disease like breast cancer, prostate cancer, colorectal cancer, lung cancer etc., respiratory diseases like cystic fibrosis etc. In hematological diseases like acute myeloid leukemia etc., molecular diagnostics tests are helpful.
Biomarkers detection for cancer disease are also done through molecular diagnostics tests.
Molecular diagnostics tests include technologies like polymerase chain reaction (PCR), next generation sequencing (NGS), In situ hybridization (ISH), mass spectrometry etc., used for the detection. Now a days, these technologies are getting advanced and automated that reduce the labor and time of results.
Roche is covering the maximum market with approximately 26 percent. Its product Cobas system is being used widely in the diagnosis of human papilloma virus (HPV), Staphylococcus aureus(SA) and methicillin-resistant Staphylococcus aureus(MRSA), Serine/threonine-protein kinase B-rafRapidly Accelerated Fibrosarcoma (BRAF) mutation test, Epidermal Growth Factor Receptor (EGFR) test etc.
Hologic Inc shares the approximately 15 percent of molecular diagnostics market. Panther system, a proprietary product of the company, used in the diagnosis of influenza A virus, influenza B virus, respiratory syncytial virus, human metapneumovirus, rhinovirus, parainfluenza virus, gram-positive bacterium Streptococcus agalactiae etc.
In 2016, Danaher Corporation acquired the Cepheid Inc a molecular diagnostics company. In August 2016, the Myriad genetics completed the acquisition of Assurex Health, Inc. In May 2016, Myriad genetics completed the acquisition of Sividon Diagnostics GmbH, a leading breast cancer prognostic company.
Key Question Covered:
- Molecular diagnostics Applications
- Global Market size of Molecular diagnostic
- Global Market size of Molecular diagnostics by application
- Global Market size of Molecular diagnostics by technologies
- North America Market size of Molecular Diagnostics
- North America Market size of Molecular diagnostics by application
- North America Market size of Molecular diagnostics by technologies
- Europe Market size of Molecular Diagnostics
- Europe Market size of Molecular diagnostics by application
- Europe Market size of Molecular diagnostics by technologies
- Asia-Pacific Market size of Molecular Diagnostics
- Asia-Pacific Market size of Molecular diagnostics by application
- Asia-Pacific Market size of Molecular diagnostics by technologies
- Patent Landscape
- Market Drivers & Resistors
- Companies and Product Profile
1. Executive Summary
2. Molecular Diagnostics: Introduction
I. History of Molecular Diagnostic
II. Concepts of Molecular Diagnostics
III. Accuracy and Precision
a. Sensitivity and Specificity
b. Molecular Diagnostic Applications and Technologies:
IV. Molecular Diagnostic Techniques
a. Polymerase Chain Reaction (PCR)
b. Real-Time qPCR
c. In Situ Hybridization (ISH or FISH)
d. DNA chips and Microarrays
e. Mass spectrometry (MS)
f. Sanger Sequencing (CE)
g. Next Generation Sequencing (NGS)
V. Molecular Diagnostic Applications
a. Oncology
b. Infectious Diseases
c. Respiratory Disorders
d. Hematology Disorders
3. Market Size of Molecular Diagnostics
I. Global Molecular Diagnostics Market
a. Region wise molecular diagnostics market
b. Global Molecular Diagnostics Market by Indication
c. Global Molecular Diagnostics Market by Technologies
II. North America Molecular Diagnostics Market
a. North America Molecular Diagnostics Market by Indication
b. North America Molecular Diagnostics Market by Technologies
III. Europe Molecular Diagnostics Market
a. Europe Molecular Diagnostics Market by Indication
b. Europe Molecular Diagnostics Market by Technologies
IV. Asia-Pacific Molecular Diagnostics Market
a. Asia-Pacific Molecular Diagnostics Market by Indication
b. Asia-Pacific Molecular Diagnostics Market by Technologies
4. Patent Landscape
I. Overall IP Trends in Molecular Diagnostics
II. Patent Trends by Focus Area
III. Patent Trends by Techniques
IV. Global Lupus Nephritis Cost of Therapy
V. Patent Trends by Targeted Organism
VI. Patent Trends by Disease Application
VII. Key Patents in the domain
VIII. Patent Trends by Key Players
a. Key Players role in patent focus
b. Key Players role in Disease Application
c. Key Players collaboration
IX. Patent Trends by Key Inventors
a. Top Inventors actively associated with the key players
5. Market Dynamics
I. Drivers
a. Rising Incidence of infectious diseases and cancer
b. Benefits of Molecular diagnostics test over Traditional Tests
c. Personalized medicine & Biomarker
d. Technological advancement
II. Restraints
a. The high cost of molecular diagnostics tests
b. Regulatory issues related to molecular diagnostics test
6. Company Overview
I. BioMerieux SA
a. Business Overview
b. Financial Overview
c. Acquisition
d. Product profile
II. Hoffmann-La Roche Ltd
a. Business Overview
b. Financial Overview
c. Product profile
III. Abbott Laboratories
a. Business Overview
b. Financial Overview
c. Product profile
IV. HologicInc
a. Business Overview
b. Financial Overview
c. Product profile
V. Siemens Healthcare GmbH
a. Business Overview
b. Financial Overview
c. Product profile
VI. Qiagen N.V.
a. Business Overview
b. Financial Overview
VII. Cepheid Inc (Subsidary of Danaher Corporation)
a. Business Overview
b. Financial Overview
c. Acquisitions
d. Product Profile
VIII. Becton, Dickinson and Company (BD)
a. Business Overview
b. Financial Overview
c. Acquisitions
d. Product Profile
IX. Myriad Genetics
a. Business Overview
b. Financial Overview
c. Acquisitions
7. About EffeMarket
8. Disclaimer
9. Contact US
Figure 1: Historical View of Molecular Diagnostics (1/1)
Figure 2: Historical View of Molecular Diagnostics (1/2)
Figure 3: Diagnostic Pathway
Figure 4: Application of Molecular Diagnostics
Figure 5: Polymerase Chain Reaction
Figure 6: Global Molecular Diagnostics Market in USD Million:2016-2026
Figure 7: Region wise Molecular Diagnostics Market in USD Million:2017
Figure 8: Global Molecular Diagnostics Market by Indication:2016-2026
Figure 9: Global Molecular Diagnostics Market by Technologies in USD Millon (2016-2026)
Figure 10: North America Molecular Diagnostics Market in USD Million (2016-2026)
Figure 11: North America Molecular Diagnostics Market by Indication in USD Million (2016-2026)
Figure 12: North America Molecular Diagnostics Market by technologies in USD Million (2016-2026)
Figure 13: Europe Molecular Diagnostics Market in USD Million (2016-2026)
Figure 14: Europe Molecular Diagnostics Market in USD Million (2016-2026)
Figure 15: Europe Molecular Diagnostics Market by technologies in USD Million (2016-2026)
Figure 16: Asia-Pacific Molecular Diagnostics Market in USD Million (2016-2026)
Figure 17: Asia-Pacific Molecular Diagnostics Market by Indication in USD Million (2016-2026)
Figure 18: Asia-Pacific Molecular Diagnostics Market by technologies in USD Million (2016-2026)
Figure 19: Publication Year Trend
Figure 20: Top Earliest Priority Country Filing Trend
Figure 21: Molecular Diagnostics - Patent Focus
Figure 22: Molecular Diagnostics - Techniques
Figure 23: Molecular Diagnostics - Targeted Organism
Figure 24: Key Patent Holders (Legal Assignees)
Figure 25: Top Inventors in the domain
Figure 26: BioMerieux SA Revenue by Business Segments: 2013-17
Figure 27: FilmarrayMultiplex PCR
Figure 28: FilmarrayMultiplex PCR Specification
Figure 29: F. Hoffmann-La Roche Revenue by Business Segment:2013-17
Figure 30: Abbott Revenue Molecular Diagnostics: 2015-17
Figure 31: Abbott Revenue Diagnostics: 2013-17
Figure 32: Abbott Revenue by Business Segment: 2013-17
Figure 33: Hologic Revenue: 2013-17
Figure 34: Hologic Revenue Diagnostics: 2013-17
Figure 35: Panther System
Figure 36: Siemens Healthineers Revenue by Business Segments: 2015-17
Figure 37: VERSANT kPCR System
Figure 38: QIAGEN N.V. Revenue Molecular diagnostics: 2013-17
Figure 39: QIAGEN N.V. Revenue 2013-17
Figure 40: Cephied Revenue 2015-17
Figure 41: Genexpert System
Figure 42: Becton, Dickinson and Company Revenue in USD Million 2017
Figure 43: Myriad Genetics Revenue 2015-2017
Table 1: Global Molecular Diagnostics Market in USD Million (2016-2026)
Table 2: Global Molecular Diagnostics Market Size by Indication in USD Million (2016-2026)
Table 3: Global Molecular Diagnostics Market Size by technologies in USD Million (2016-2026)
Table 4: North America Molecular Diagnostics Market in USD Million (2016-2026)
Table 5: North America Molecular Diagnostics Market Size by Indication in USD Million (2016-2026)
Table 6: North America Molecular Diagnostics Market Size by technologies in USD Million (2016-2026)
Table 7: Europe Molecular Diagnostics Market in USD Million (2016-2026)
Table 8: Europe Molecular Diagnostics Market Size by Indication in USD Million (2016-2026)
Table 9: Europe Molecular Diagnostics Market Size by technologies in USD Million (2016-2026)
Table 10: Asia-Pacific Molecular Diagnostics Market in USD Million (2016-2026)
Table 11: Asia-Pacific Molecular Diagnostics Market Size by Indication in USD Million (2016-2026)
Table 12: Asia-Pacific Molecular Diagnostics Market Size by technologies in USD Million (2016-2026)
Table 13: Molecular Diagnostics - Patent Focus (2015-2018)
Table 14: Molecular Diagnostics - Techniques (2015-2018)
Table 15: Molecular Diagnostics - Disease Application (2015-2018)
Table 16: Key Patents in the domain
Table 17: Key Players Year Wise Patent Publication (2015-2018)
Table 18: Key Players role in patent focus
Table 19: Key Players role in Techniques
Table 20: Key Players role in Techniques
Table 21: Key Players collaboration
Table 22: Key Players collaboration
Table 23: Filmarray Multiplex PCR Specification